Gf Fund Management Co. Ltd. Krystal Biotech, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.62 Trillion
- Q4 2024
A detailed history of Gf Fund Management Co. Ltd. transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 604 shares of KRYS stock, worth $110,302. This represents 0.0% of its overall portfolio holdings.
Number of Shares
604Holding current value
$110,302% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding KRYS
# of Institutions
299Shares Held
24.3MCall Options Held
388KPut Options Held
233K-
Black Rock Inc. New York, NY3.95MShares$721 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.88MShares$526 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.63MShares$480 Million6.0% of portfolio
-
State Street Corp Boston, MA1.28MShares$234 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA879KShares$161 Million0.02% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.69B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...